BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7312107)

  • 1. [Effect of phenytoin and carbamazepine treatment on nonspecific immunological reactivity in epilepsy].
    Członkowska A; Niedzielska K; Korlak J
    Neurol Neurochir Pol; 1981; 15(3):297-302. PubMed ID: 7312107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunologic aspects of carbamazepine treatment in epileptic patients.
    Pacifici R; Paris L; Di Carlo S; Pichini S; Zuccaro P
    Epilepsia; 1991; 32(1):122-7. PubMed ID: 1985820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA antigens in epileptic patients with drug-induced immunodeficiency.
    Gilhus NE; Aarli JA; Thorsby E
    Int J Immunopharmacol; 1982; 4(6):517-20. PubMed ID: 7152760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin abnormalities in epileptic patients treated with diphenylhydantoin.
    Yabuki S; Nakaya K
    Folia Psychiatr Neurol Jpn; 1976; 30(2):93-109. PubMed ID: 971887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum IgA deficiency induced by prolonged phenytoin treatment.
    Talesnik E; Rivero SJ; González B
    Rev Invest Clin; 1989; 41(4):331-5. PubMed ID: 2631168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Non-specific immunologic reactivity in epilepsy].
    Członkowska A; Korlak J
    Neurol Neurochir Pol; 1980; 14(4):353-8. PubMed ID: 6968044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Decrease of folic acid and cognitive alterations in patients with epilepsy treated with phenytoin or carbamazepine, pilot study].
    Hernández R; Fernández Mde L; Miranda G; Suástegui R
    Rev Invest Clin; 2005; 57(4):522-31. PubMed ID: 16315636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Depression of immune competence by phenytoin and carbamazepine. Studies in vivo and in vitro.
    Sorrell TC; Forbes IJ
    Clin Exp Immunol; 1975 May; 20(2):273-85. PubMed ID: 1212810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral and cellular immune parameters in untreated and phenytoin-or carbamazepine-treated epileptic patients.
    Başaran N; Hincal F; Kansu E; Ciğer A
    Int J Immunopharmacol; 1994 Dec; 16(12):1071-7. PubMed ID: 7705969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte subpopulations and lymphocyte function in phenytoin-treated patients with epilepsy.
    Gilhus NE; Matre R; Aarli JA
    Int J Immunopharmacol; 1982; 4(1):43-8. PubMed ID: 6979523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IgA, IgG, and IgM concentrations in patients with epilepsy and matched controls: a cohort-based cross-sectional study.
    Ranua J; Luoma K; Auvinen A; Peltola J; Haapala AM; Raitanen J; Isojärvi J
    Epilepsy Behav; 2005 Mar; 6(2):191-5. PubMed ID: 15710303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient phenytoin induced IgA deficiency and permanent IgE increase.
    Blanco A; Palencia R; Solis P; Arranz E; Sánchez Villares E
    Allergol Immunopathol (Madr); 1986; 14(6):535-8. PubMed ID: 3030084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in serum immunoglobulin levels during phenytoin treatment of epilepsy.
    Aarli JA
    Acta Neurol Scand; 1976 Nov; 54(5):423-30. PubMed ID: 998166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Serum lipids. lipoproteins, and apolipoproteins in adult epileptics treated with carbamazepine, valproic acid, or phenytoin].
    Pita-Calandre E; Rodríguez-López CM; Cano MD; Peña-Bernal M
    Rev Neurol; 1998 Nov; 27(159):785-9. PubMed ID: 9859151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum immunoglobulins, complement levels and lymphocyte subpopulations in phenytoin-treated epileptic patients.
    Başaran N; Kansu E; Hincal F
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):335-46. PubMed ID: 2621321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IgA deficiency, epilepsy, and phenytoin treatment.
    Seager J; Jamison DL; Wilson J; Hayward AR; Soothill JF
    Lancet; 1975 Oct; 2(7936):632-5. PubMed ID: 52004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of phenytoin and carbamazepine on evoked potentials in patients with newly diagnosed epilepsy. Part I. Visual evoked potentials].
    Rysz A; Gajkowski K
    Neurol Neurochir Pol; 1996; 30(6):961-9. PubMed ID: 9173334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA deficiency and systemic lupus erythematosus. Occurrence in an oriental woman with idiopathic epilepsy.
    Takigawa M; Kanoh T; Imamura S; Takahashi C
    Arch Dermatol; 1976 Jun; 112(6):845-9. PubMed ID: 782364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-induced IgA deficiency in epileptic patients.
    Aarli JA
    Arch Neurol; 1976 Apr; 33(4):296-9. PubMed ID: 1259644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.